Latest News and Press Releases

Intravacc and SynphaBase Announce Strategic Partnership to Advance Conjugate Vaccine Development

Intravacc and SynphaBase Announce Strategic Partnership to Advance Conjugate Vaccine Development

Les deux entreprises uniront leurs compétences complémentaires en matière d’oligosaccharides synthétiques, de développement de procédés de conjugaison et de fabrication de vaccins selon les BPF afin...

Die Unternehmen werden ihr komplementäres Fachwissen in den Bereichen synthetische Oligosaccharide, Entwicklung von Konjugationsverfahren und GMP-konformer Impfstoffherstellung bündeln, um Partner bei...

Intravacc and Primrose Bio Renew Partnership to Enhance Conjugate Vaccine Development.

Intravacc and Primrose Bio Renew Partnership to Enhance Conjugate Vaccine Development.

Dublin, March 09, 2026 (GLOBE NEWSWIRE) -- The "Pneumovax 23 Market Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts" has been added to ResearchAndMarkets.com's...

Dublin, March 09, 2026 (GLOBE NEWSWIRE) -- The "Menveo Market Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts" has been added to ResearchAndMarkets.com's offering. ...

Dublin, March 09, 2026 (GLOBE NEWSWIRE) -- The "Prevnar Market Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts" has been added to ResearchAndMarkets.com's offering. ...

Delray Beach, FL, Feb. 13, 2026 (GLOBE NEWSWIRE) -- The Global Conjugate Vaccines Market is projected to reach USD 21.77 billion by 2030 from USD 15.25 billion in 2025, at a CAGR of 7.4% from 2025...